MTOR and myeloid sarcoma: Further, the compelling reasons have shown that mTOR dysregulation is explained by the progress of autoimmune diseases, including cancer cells, diabetes mellitus (DM), and multiple sclerosis (MS) (Blagosklonny, 2013; Giacoppo et al., 2017)